Document Detail


Labetalol and other agents that block both alpha- and beta-adrenergic receptors.
MedLine Citation:
PMID:  8124849     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Labetalol, a compound that blocks both alpha- and beta-adrenergic receptors, is the only drug of its class currently available in the United States. OBJECTIVE: To review the pharmacology of labetalol and related compounds. SUMMARY: Unlike "pure" beta blockers, labetalol maintains cardiac output, reduces total peripheral resistance, and does not decrease peripheral blood flow. It has been used to treat hypertension of all degrees of severity and may be especially useful in black patients, elderly patients, patients with renal disease, and in pregnancy. It can be used in conditions that produce catecholamine crises, such as pheochromocytoma, clonidine withdrawal, and cocaine overdose. Its hemodynamic profile is attractive for use in myocardial ischemia. The parenteral form is useful in situations where blood pressure must be lowered quickly. The major side effect is orthostatic hypotension, and hepatotoxicity has been reported. CONCLUSIONS: Labetalol has several advantages over pure beta-blocking drugs and offers an alternative in managing hypertension that is difficult to control.
Authors:
C J Pearce; J D Wallin
Related Documents :
1032569 - Studies with a new cardioselective beta-blocker, metoprolol.
627129 - Concurrent antagonism of isoproterenol and norepinephrine after labetalol.
6152739 - Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade.
15155109 - Are there any benefits of betoptic s (betaxolol hcl ophthalmic suspension) over other b...
12241539 - The trp64arg beta3-adrenergic receptor amino acid variant confers increased sensitivity...
6146329 - Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and s...
21921829 - Influence of pressure control levels on the pulse pressure variations: an animal study ...
9024829 - Changes in adenine nucleotides during hemorrhagic shock and reperfusion.
11208749 - Effects of blood pressure, smoking, and their interaction on carotid artery structure a...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cleveland Clinic journal of medicine     Volume:  61     ISSN:  0891-1150     ISO Abbreviation:  Cleve Clin J Med     Publication Date:    1994 Jan-Feb
Date Detail:
Created Date:  1994-04-12     Completed Date:  1994-04-12     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8703441     Medline TA:  Cleve Clin J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  59-69; quiz 80-2     Citation Subset:  IM    
Affiliation:
Department of Medicine, Louisiana State University School of Medicine, New Orleans 70112.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Labetalol* / adverse effects,  pharmacology,  therapeutic use
Chemical
Reg. No./Substance:
36894-69-6/Labetalol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ovarian cancer update: management challenges and advances.
Next Document:  Intrahepatic cholestasis during nicotinic acid therapy.